SHARE THIS VIDEO —
Novo Nordisk CEO defends high price off Ozempic and Wegovy
NBC News Clone summarizes the latest on: Mmvo218031173960 - Breaking News | NBC News Clone. This article is rewritten and presented in a simplified tone for a better reader experience.
NBC News' Meagan Fitzgerald sits down with Novo Nordisk CEO Lars Jorgenson in Denmark to discuss the high costs and limited supply of the company's popular weight loss drugs, Ozempic and Wegovy.
Stay informed with daily digest and insights from NBC News Clone. We repackage top headlines for our global readers.
